Verified Evidence: resolved · Fact Lock: locked · QA: pass
Google DeepMind has released AlphaGenome 2, according to MarkTechPost, which describes the system as a conditional DNA sequence model designed to predict regulatory activity and genetic variant effects for specific cell types.

MarkTechPost reported that AlphaGenome 2 focuses on cell-type-specific analysis, linking DNA sequences to predictions about regulatory activity and the effects of genetic variants. The description identifies Google DeepMind as the organization behind the model.

The same report said the model is available through the AlphaGenome API for non-commercial research. The supplied evidence does not independently corroborate the release, and it does not establish a physical release location or confirm that the report’s publication date was the product’s release date.

SOURCES

  1. MarkTechPostGoogle DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects